BloggingStocks has a new home! Daily Finance.
Click here to visit the new home of BloggingStocks!
The Richest Woman in the World: How Gina Rinehart Earns her Billions
America's 10 Highest-Paid CEOs of 2011 (and How They Earned It)HumanGenomeSciences posts
Feed
Today was all about much better than expected GDP reports. The lackluster jobless claims failed to even make a ripple after the GDP marked an unofficial end of the recession. The market absorbed over $500 million in secondary offerings like it was a stick of butter being put on a giant baked potato. Continue reading Closing Bell: Recession-end sells the short-sellers (PG, HGSI, FSLR, AMSC, TSPT)
News events of the day are providing a dramatic illustration that not all biotech companies are the same.
Just as President Obama lifted the executive order banning the use of embryonic stem cells for research, Roche and Genentech (NYSE: DNA) appear to have reached an agreement on Roche's bid to acquire the 44% of DNA that Roche does not currently own.
Shares of biotech companies engaged in stem cell protocols rallied after the Obama announcement. While most of these companies are small in size with stock prices below $2 per share, the announcement gave impetus to price increases of 17% to 100%.
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update